We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Tivicay and Tivicay PD
Australian Public Assessment Report
Device/Product Name
Tivicay and Tivicay PD
Active ingredients
Dolutegravir (as sodium)
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-03495-1-2
Submission Type
Extension of indications, and new dose form
Decision
Approved